AM
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Routine infectious disease consultation prior to an allogeneic hematopoietic cell transplant | Open forum infectious diseases |  | 2023 | 39 | 33 | ||
| Pharmacokinetic parameters and weight change in HIV patients newly switched to dolutegravir-based regimens in SIMPL'HIV clinical trial | British journal of clinical pharmacology |  | 2021 | 171 | 0 | ||
| Viral Infections and Cutaneous Drug-Related Eruptions | Frontiers in pharmacology | | 2021 | 162 | 98 | ||
| Caring for people living with HIV during the global coronavirus disease 2019 pandemic | AIDS | | 2021 | 198 | 0 | ||
| Prophylaxis for COVID-19: a systematic review | Clinical microbiology and infection | | 2021 | 67 | 34 | ||
| Post-exposure Lopinavir-Ritonavir Prophylaxis versus Surveillance for Individuals Exposed to SARS-CoV-2: The COPEP Pragmatic Open-Label, Cluster Randomized Trial | EClinicalMedicine | | 2021 | 584 | 112 | ||
| Possible link between anosmia and COVID-19: sniffing out the truth | European Archives of Oto-Rhino-Laryngology | | 2020 | 161 | 138 | ||
| Efficacy and safety of dolutegravir plus emtricitabine versus standard ART for the maintenance of HIV-1 suppression: 48-week results of the factorial, randomized, non-inferiority SIMPL'HIV trial | PLoS medicine | | 2020 | 160 | 112 | ||
| Efficacy of pragmatic same-day ring prophylaxis for adult individuals exposed to SARS-CoV-2 in Switzerland (COPEP): protocol of an open-label cluster randomised trial | BMJ Open | | 2020 | 213 | 94 |
